H
HilleVax D
D
HLVX
1.91000
USD
-0.01
(-0.52%)
Market Closed
Volume
2,757
EPS
-3
Div Yield
-
P/E
-1
Market Cap
95,129,594
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: HilleVax
Sector: Healthcare
Industry: Biotechnology
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.